UroGen Pharma URGN
NASDAQ URGN
$34.49 -0.66 (-1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Amortization of Deferred Charges (2022 - 2026)

Updated

Analysis

UroGen Pharma (URGN) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 UroGen Pharma 1.73 Bn 1.24 Bn 65.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -796,000.00
Mar 31, 2026 1.97 Mn
Dec 31, 2025 99,000.00
Sep 30, 2025 -397,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 374,000.00
Dec 31, 2024 25,000.00
Sep 30, 2024 -592,000.00
Jun 30, 2024 223,000.00
Mar 31, 2024 -961,000.00
Dec 31, 2023 33,000.00
Sep 30, 2023 222,000.00
Jun 30, 2023 355,000.00
Mar 31, 2023 404,000.00
Dec 31, 2022 677,000.00
Sep 30, 2022 674,000.00
Jun 30, 2022 121,000.00
Mar 31, 2022 282,000.00
API Access

UroGen Pharma Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=URGN&period=max&api_key=YOUR_API_KEY